The authors summarize a clinical trial involving transplantation of purified autologous fluorescence-activated cell sorting (FACS)-sorted CD34 + Thy 1 + Lin -peripheral blood cells in patients with myeloma. The grafts from three patients were tested for tumor contamination and contained no detectable clonal myeloma cells. Engraftment occurred in all patients but was delayed in some. This approach and other strategies involving positive selection of stem cells may be refined in future studies as a method for eliminating tumor cells that may contaminate an autologous transplant. As an alternative to positive selection of hematopoietic stem cells based on CD34 expression, a method for isolating stem cells and progenitors is described in this report that uses a fluorescent substrate for the enzyme aldehyde dehydrogenase (ALDH). This technique may be useful for isolating stem cells from other tissues as well. Twenty-one children underwent cord blood transplant following a reduced-intensity conditioning regimen. Seventy-five percent of the recipients demonstrated sustained engraftment. Since cord blood is a near universal source of hematopoietic stem cells and since reducedintensity regimens are less toxic than traditional myeloablative conditioning regimens, this approach to hematopoietic stem cell transplantation may allow a greater number of transplants to be performed more safely than previously possible. The authors provide an excellent summary of the attempts to expand hematopoietic stem cells and the challenges that need to be surmounted to achieve this. Successful expansion of stem cells could revolutionize the practice of bone marrow transplantation by providing a greater number and quantity of acceptable hematopoietic stem cell grafts than currently available. 
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factors can differentially affect the ability of HSCs to execute a self-renewal division within a single cell cycle, even when the kinetics of proliferation are the same. These types of studies will be important for defining the environmental and genetic events that govern the developmental fate of stem cells. Understanding these processes is critical to developing techniques for successfully expanding stem cells. The Hox family of transcription factors have emerged as important regulators of primitive hematopoietic cell proliferation and differentiation. In this study, the authors found that HOXB4 expression supported high-level ex vivo hematopoietic stem cell (HSC) expansion. HSCs transduced to express HOXB4 retained full lymphomyeloid repopulating potential and had enhanced in vivo regenerative potential,demonstrating the feasibility of achieving significant ex vivo expansion of HSCs without functional impairment. The development of safe pharmacologic versions of HOXB4 or the identification of inducers of endogenous HOXB4 expression might be useful in efforts to expand stem cells for transplantation purposes. Human CD34 + subsets were transduced with lentiviral vectors expressing the luciferase gene. The fate and distribution of cells were then followed using a novel in vivo imaging system. The authors used state-of-the-art gene transfer procedures to mark human progenitor cells and then followed the behavior of these over time in a living animal.
